Mirum Pharmaceuticals Inc (MIRM)
43.48
-0.21
(-0.48%)
USD |
NASDAQ |
Nov 21, 16:00
43.48
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Profit Margin (Quarterly): -15.75% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -15.75% |
| June 30, 2024 | -31.64% |
| March 31, 2024 | -36.52% |
| December 31, 2023 | -51.27% |
| September 30, 2023 | -49.42% |
| June 30, 2023 | -197.5% |
| March 31, 2023 | -95.35% |
| Date | Value |
|---|---|
| December 31, 2022 | -130.5% |
| September 30, 2022 | -190.1% |
| June 30, 2022 | -154.0% |
| March 31, 2022 | -283.9% |
| December 31, 2021 | |
| September 30, 2021 | -942.2% |
| June 30, 2021 | -399.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-942.2%
Minimum
Sep 2021
-15.75%
Maximum
Sep 2024
-198.2%
Average
-130.5%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
| Arcutis Biotherapeutics Inc | -92.81% |
| Cytokinetics Inc | -34.67K% |
| Amicus Therapeutics Inc | -4.75% |
| MannKind Corp | 16.48% |
| TG Therapeutics Inc | 4.63% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -41.13% |
| Return on Assets | -15.22% |
| Return on Invested Capital | -18.16% |
| Gross Profit Margin (Quarterly) | 76.98% |
| Operating Margin (Quarterly) | -14.03% |
| Return on Net Operating Assets | -29.02% |